API
< Back to all clusters
[HEALTH] · South Korea, Japan · 6 sources

started · updated

South Korea establishes task force to crack down on illegal obesity drug sales

The South Korean Ministry of Food and Drug Safety (MFDS) has launched a special task force to combat the illegal distribution of GLP-1 class obesity treatments, such as Wegovy and Mounjaro. This move follows recent government permission allowing individuals to carry up to a three-month supply of these medications when traveling from abroad for personal use.

Authorities are targeting illegal activities including online advertisements, second-hand trading on platforms, and social media solicitation. The task force will monitor blogs, cafes, and one-on-one chats to identify illegal sellers. Under the Pharmaceutical Affairs Act, individuals who resell or give away medications brought in from abroad for personal use face up to five years in prison or fines of up to 50 million won.

The crackdown comes amid the rise of “Sushijaro,” a term referring to patients traveling to Japan to purchase Mounjaro at significantly lower prices than in South Korea. Digital tools, including apps that compare Japanese hospital prices and locations, have emerged to facilitate these trips.

Medical professional groups, including the Korean Society for the Study of Obesity, have called for improved safety management and discussions regarding drug price reductions and health insurance coverage. They expressed concerns that while overseas purchasing reduces costs, it may lead to improper dosing, lack of medical supervision, and potential misuse of these prescription drugs.

Entities

Eli Lilly · Japan · Ministry of Food and Drug Safety · Mounjaro · Mounjaro · South Korea · Wegovy · Wegovy